| Gufic BioSciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 509079 |
NSE Symbol : GUFICBIO |
P/E(TTM) : 56.79 |
|
ISIN Demat : INE742B01025 |
Div & Yield% : 0.02 |
EPS(TTM) : 7.33 |
|
Book Value(₹) : 66.23 |
Market Cap(₹Cr) : 4,174.26 |
Face Value(₹) : 1.00 |
| Particulars | Dec '26 | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 940.48 | 819.81 | 806.67 | 690.62 | 779.16 |
| Other Income | 2.58 | 3.62 | 2.18 | 2.57 | 3.10 |
| Stock Adjustments | 68.95 | 24.91 | -0.57 | 33.39 | 19.39 |
| Total Income | 1,012.01 | 848.34 | 808.28 | 726.58 | 801.65 |
| EXPENDITURE : | |||||
| Raw Materials | 490.15 | 399.62 | 389.32 | 365.21 | 431.35 |
| Power and Fuel Cost | 32.34 | 18.46 | 17.61 | 15.24 | 11.00 |
| Other Manufacturing Expenses | 45.53 | 29.25 | 28.43 | 24.67 | 27.42 |
| Selling and Administration Expenses | 129.36 | 121.79 | 105.28 | 87.63 | 77.97 |
| Miscellaneous Expenses | 10.02 | 12.03 | 8.48 | 9.88 | 17.16 |
| Employee Benefit Expenses | 151.68 | 127.19 | 109.67 | 86.73 | 85.61 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 152.93 | 140.01 | 149.48 | 137.22 | 151.14 |
| Interest | 36.61 | 24.52 | 16.79 | 8.22 | 5.37 |
| Gross Profit | 116.32 | 115.49 | 132.69 | 129.00 | 145.77 |
| Depreciation | 30.83 | 21.06 | 17.02 | 22.28 | 18.93 |
| Profit Before Tax | 85.49 | 94.43 | 115.67 | 106.72 | 126.84 |
| Current Tax | 13.70 | 18.74 | 26.37 | 28.21 | 32.15 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 8.63 | 5.75 | 3.17 | -1.19 | -1.15 |
| Reported Net Profit | 63.15 | 69.93 | 86.14 | 79.70 | 95.84 |
| Extraordinary Items | 0.00 | 0.15 | -1.67 | 0.02 | 0.05 |
| Adjusted Net Profit | 63.15 | 69.78 | 87.81 | 79.68 | 95.79 |
| Adjustment below Net Profit | 0.10 | -0.10 | 0.00 | 0.00 | 0.00 |
| Profit/Loss Balance carried down | 421.28 | 352.46 | 267.29 | 188.55 | 93.68 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 1.00 | 1.00 | 0.97 | 0.97 | 0.97 |
| P & L Balance carried down | 483.53 | 421.28 | 352.46 | 267.29 | 188.55 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Dividend Per Share(Rs) | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 |
| Earnings Per Share-Unit Curr | 6.30 | 6.97 | 8.59 | 8.22 | 9.89 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 66.23 | 59.96 | 53.11 | 35.88 | 27.76 |
| Book Value(Adj)-Unit Curr | 66.23 | 59.96 | 53.11 | 35.88 | 27.76 |
